Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery

Journal of the American Chemical Society

Volumn 126, Issue 32, 2004, Pages 10044-10048

  Chen, Hui Ting ^a   Neerman, Michael F ^a   Parrish, Alan R ^b   Simanek, Eric E ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; DRUG PRODUCTS; MELAMINE; NITROGEN; TOXICITY; UREA;

CYTOTOXICITY; HEMOLYSIS; PRECURSORS;

DENDRIMERS;

ALANINE AMINOTRANSFERASE; AMINE; CARBOXYLIC ACID DERIVATIVE; DENDRIMER; GUANIDINE DERIVATIVE; MELAMINE; PHOSPHONIC ACID DERIVATIVE; SULFONIC ACID DERIVATIVE; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; CYTOTOXICITY; HEMOLYSIS; MOUSE; NONHUMAN; SYNTHESIS; UREA NITROGEN BLOOD LEVEL;

ANIMALS; COMPUTER SIMULATION; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HEMOLYSIS; MALE; MICE; MICE, INBRED C3H; MODELS, MOLECULAR; POLYETHYLENE GLYCOLS; RESINS, SYNTHETIC; TRIAZINES;

EID: 4043103282     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja048548j     Document Type: Article

References (35)

1. (a) Stiriba, S.-E.; Frey, H.; Haag, R. Angew. Chem., Int. Ed. 2002, 41, 1329.
2. (b) Aulenta, F.; Hayes, W.; Rannard, S. Eur. Polym. J. 2003, 39, 1741.
3. (c) Cloninger, M. J. Curr. Opin. Chem. Biol. 2002, 6, 742.
4. (d) Esfand, R.; Tomalia, D. A. Drug Discovery Today 2001, 6, 427-436.
5. (e) Patri, A. K.; Majoros, I. J.; Baker, J. R., Jr. Curr. Opin. Chem. Biol. 2002, 6, 466.
6. Duncan, R. Nat. Rev. Drug Discovery 2003, 2, 347.
7. (a) Maeda, H. Adv. Enzyme Regul. 2001, 41, 189.
8. (b) Matsumura, Y.; Maeda, H. Cancer Res. 1986, 6, 6387.
9. (c) Greish, K.; Fang, J.; Inutsuka, T.; Nagamitsu, A.; Maeda, H. Clin. Pharmacokinet. 2003, 42, 1089.
10. (a) Zhang, W.; Tichy, S. E.; Pérez, L. M.; Maria, G.; Lindahl, P. A.; Simanek, E. E. J. Am. Chem. Soc. 2003, 125, 5086.
11. (b) Zhang, W.; Nowlan, D. T., III; Thomson, L. M.; Lackowski, W. M.; Simanek, E. E. J. Am. Chem. Soc. 2001, 123, 8914.
12. (c) Steffensen, M. B.; Simanek, E. E. Org. Lett. 2003, 5, 2359.
13. (d) Zhang, W.; Gonzalez, S. O.; Simanek, E. E. Macromolecules 2002, 35, 9015.
14. Zhang, W.; Jiang, J.; Qin, C.; Thomson, L. M.; Parrish, A. R.; Safe, S. H.; Simanek, E. E. Supramol. Chem. 2003, 15, 607.
15. (a) Neerman, M. F.; Chen, H. T.; Parrish, A. R.; Simanek, E. E. Unpublished results.
16. (b) Neerman, M. F.; Zhang, W.; Parrish, A. R.; Simanek, E. E. Int. J. Pharm. In press.
17. For a detailed description of dendrimer syntheses, including this hypercore approach, see: Grayson, S. M.; Fréchet, J. M. J. Chem. Rev. 2001, 101, 3819.
18. MTBD = 7-methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene. Schwesinger, R. Chimia 1985, 39, 269.
19. BEMP = 2-tert-hutylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2- diazaphosphorine. (a) Schwesinger, R. Schlemper, H. Angew. Chem., Int. Ed. Engl. 1987, 26, 1167.
20. (b) O'Donnell, M. J.; Delgado, F.; Hostettler, C.; Schwesinger, R. Tetrahedron Lett. 1998, 39, 8775.
21. TBD = 1,5,7-triazabicyclo[4.4.0]dec-5-ene. (a) Xu, W.; Mohan, R.; Morrissey, M. M. Tetrahedron Lett. 1997, 38, 7337.
22. (b) Weidner, J. J.; Parlow, J. J.; Flynn, D. L. Tetrahedron Lett. 1999, 40, 239.
23. Shuttleworth, S. J.; Nasturica, D.; Gervais, C.; Siddiqui, M. A.; Rando, R. F.; Lee, N. Bioorg. Med. Chem. Lett. 2000, 10, 2501.
24. As per Larsen, S. D.; Connell, M. A.; Cudahy, M. M.; Evans, B. R.; May, P. D.; Meglasson, M. D.; O'Sullivan, T. J.; Schostarez, H. J.; Sih, J. C.; Stevens, F. C.; Tanis, S. P.; Tegley, C. M.; Tucker, J. A.; Vaillancourt, V. A.; Vidmar, T. J.; Watt, W.; Yu, J. H. J. Med. Chem. 2001, 44, 1217.
25. As per Trester-Zedlitz, M.; Kamada, K.; Burley, S. K.; Fenyö, D.; Chait, B. T.; Muir, T. W. J. Am. Chem. Soc. 2003, 125, 2416.
26. As per Adamczyk, M.; Chen, Y.-Y.; Mattingly, P. G.; Pan, Y.; Rege, S. J. Org. Chem. 1998, 63, 5636.
27. Rosowsky, A,; Forsch, R. A.; Moran, R. G.; Kohler, W.; Freisheim, J. H. J. Med. Chem. 1988, 31, 1326.
28. Palacios, F.; Aparicio, D.; Vicario, J. Eur. J. Org. Chem. 2002, 24, 4131.
29. As per Kojima, C.; Kono, K.; Maruyama, K.; Takagishi, T. Bioconjugate Chem. 2000, 11, 910.
30. Carreño-Gómez, B.; Duncan, R. Int. J. Pharm. 1997, 148, 231.
31. Fischer, D.; Li, Y.; Ahlemeyer, B.; Krieglstein, J.; Kissel, T. Biomaterials 2003, 24, 1121.
32. Mosmann, T. J. Immunol. Methods 1983, 65, 55.
33. (a) Sgouras, D.; Duncan, R. J. Mater. Sci.: Mater. Med. 1990, 1, 61.
34. (b) Malik, N.; Wiwattanapatapee, R.; Klopsch, R.; Lorenz, K.; Frey, H.; Weener, J. W.; Meijer, E. W.; Paulus, W.; Duncan, R. J. Controlled Release 2000, 65, 133.
35. Padilla De Jesus, O. L.; Ihre, H. R.; Gagne, L.; Fréchet, J. M. J.; Szoka, F. C., Jr. Bioconjugate Chem. 2002, 13, 453.